ArticleBMJ mental health2026
Weight loss prior to diagnosis of first-episode psychosis predicts subsequent weight gain: a retrospective cohort study of the UK Clinical Practice Research Datalink (CPRD) primary care database.
Article in BMJ mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPost-psychosis weight gain is commonly rapid, yet prediagnosis weight changes are under-researched. The untreated phase of first-episode psychosis (FEP) can be characterised by behaviour which could lead to weight loss, triggering physiological adaptations which prime the body to regain weight.
objectiveWe aimed to investigate the prevalence and extent of weight loss prior to diagnosis of FEP, and to investigate its impact on subsequent weight gain.
methodsWe used Clinical Practice Research Datalink primary care data, supplemented with linked hospital episode statistics, ethnicity and deprivation data to estimate pre-FEP weight loss prevalence. We then used multiple linear regression to assess its association with subsequent weight change, while adjusting for relevant confounders.
findingsPrimary analysis included 369 individuals with adequate data. 53% of individuals experienced weight loss before FEP. Using percentage weight change as an outcome, individuals with pre-FEP weight loss gained weight post-FEP at over twice the rate of those without prior loss (8.93% (95% CI 6.90% to 10.96%) bodyweight per year vs 4.07% per year (95% CI 1.90% to 6.24%); p=0.005). Each 1% of pre-FEP weight loss predicted 0.41% (95% CI 0.23% to 0.59%) additional annual weight gain (p=0.004), most pronounced within 6 months and independent of antipsychotic treatment selection. Using kilogram per year as an outcome, average gain (6.49 kg (95% CI 5.28 kg to 7.70 kg)) exceeded average prior loss (4.83 kg (95% CI 4.00 kg to 5.66 kg)) by 1 year. Findings were robust across sensitivity analyses.
conclusionsPre-FEP weight loss is common and predicts rapid post-diagnosis gain. While all patients were expected to gain weight, those with pre-FEP weight loss gained double the weight of those who had not lost weight. CLINICAL IMPLICATIONS: Clinicians treating individuals with FEP should enquire about weight loss in the pretreatment period, which predicts extra weight gain in the initial period following diagnosis. This could inform early intervention to avoid consequences of short-term weight gain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.